Urology Case Reports (Mar 2018)

Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

  • Eugene Shenderov,
  • Michael A. Gorin,
  • Seohyun Kim,
  • Pamela T. Johnson,
  • Mohamad E. Allaf,
  • Alan W. Partin,
  • Martin G. Pomper,
  • Emmanuel S. Antonarakis,
  • Kenneth J. Pienta,
  • Steven P. Rowe

DOI
https://doi.org/10.1016/j.eucr.2017.12.011
Journal volume & issue
Vol. 17, no. C
pp. 22 – 25

Abstract

Read online

Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

Keywords